1. Home
  2. CYTK vs OSK Comparison

CYTK vs OSK Comparison

Compare CYTK & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$59.89

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Logo Oshkosh Corporation

OSK

Oshkosh Corporation

N/A

Current Price

$150.37

Market Cap

11.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
OSK
Founded
1997
1917
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
11.0B
IPO Year
2004
2009

Fundamental Metrics

Financial Performance
Metric
CYTK
OSK
Price
$59.89
$150.37
Analyst Decision
Strong Buy
Buy
Analyst Count
18
14
Target Price
$87.56
$166.36
AVG Volume (30 Days)
1.7M
675.7K
Earning Date
05-25-2026
04-29-2026
Dividend Yield
N/A
1.50%
EPS Growth
N/A
N/A
EPS
N/A
1.14
Revenue
$13,368,000.00
$7,705,500,000.00
Revenue This Year
$9.79
$6.18
Revenue Next Year
$302.66
$6.56
P/E Ratio
N/A
$133.65
Revenue Growth
N/A
12.83
52 Week Low
$29.31
$76.82
52 Week High
$70.98
$180.49

Technical Indicators

Market Signals
Indicator
CYTK
OSK
Relative Strength Index (RSI) 40.30 37.15
Support Level $59.25 $123.32
Resistance Level $65.93 $158.53
Average True Range (ATR) 2.65 5.84
MACD -0.32 -3.21
Stochastic Oscillator 3.98 7.91

Price Performance

Historical Comparison
CYTK
OSK

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About OSK Oshkosh Corporation

Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.

Share on Social Networks: